Lei Han

机构：Qingdao Agricultural University, Shanghai Jiao Tong University, Shanghai First People's Hospital, Affiliated Hospital of Jining Medical University · ORCID：0000-0001-6007-9716

发表论文 68 篇 · 总被引 525 次 · h-index 13

代表论文

• Construction and Validation of TACE Therapeutic Efficacy by ALR Score and Nomogram: A Large, Multicenter Study (2023 · Journal of Hepatocellular Carcinoma · 被引 42)
• Decoding the potential role of regulatory T cells in sepsis‐induced immunosuppression (2024 · European Journal of Immunology · 被引 23)
• Dissipation kinetics, residue level, and risk assessment of chlorantraniliprole in Rosa roxburghii and its residue removal using household decontamination technique (2024 · Quality Assurance and Safety of Crops & Foods · 被引 21)
• PD-1 Inhibitors Combined with Antiangiogenic Therapy with or Without Transarterial Chemoembolization in the Treatment of Hepatocellular Carcinoma: A Propensity Matching Analysis (2023 · Journal of Hepatocellular Carcinoma · 被引 21)
• Finotonlimab (PD-1 inhibitor) plus bevacizumab (bevacizumab biosimilar) as first-tier therapy for late-stage hepatocellular carcinoma: a randomized phase 2/3 trial (2025 · Signal Transduction and Targeted Therapy · 被引 20)
• A single-cell atlas of lung homeostasis reveals dynamic changes during development and aging (2024 · Communications Biology · 被引 18)